Literature DB >> 26131963

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids.

Viviana Meraviglia1, Alessandra Zanon1, Alexandros A Lavdas1, Christine Schwienbacher1, Rosamaria Silipigni2, Marina Di Segni2, Huei-Sheng Vincent Chen3, Peter P Pramstaller1, Andrew A Hicks1, Alessandra Rossini4.   

Abstract

Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by forcing the expression of four transcription factors (Oct-4, Sox-2, Klf-4, and c-Myc), typically expressed by human embryonic stem cells (hESCs). Due to their similarity with hESCs, iPSCs have become an important tool for potential patient-specific regenerative medicine, avoiding ethical issues associated with hESCs. In order to obtain cells suitable for clinical application, transgene-free iPSCs need to be generated to avoid transgene reactivation, altered gene expression and misguided differentiation. Moreover, a highly efficient and inexpensive reprogramming method is necessary to derive sufficient iPSCs for therapeutic purposes. Given this need, an efficient non-integrating episomal plasmid approach is the preferable choice for iPSC derivation. Currently the most common cell type used for reprogramming purposes are fibroblasts, the isolation of which requires tissue biopsy, an invasive surgical procedure for the patient. Therefore, human peripheral blood represents the most accessible and least invasive tissue for iPSC generation. In this study, a cost-effective and viral-free protocol using non-integrating episomal plasmids is reported for the generation of iPSCs from human peripheral blood mononuclear cells (PBMNCs) obtained from frozen buffy coats after whole blood centrifugation and without density gradient separation.

Entities:  

Mesh:

Year:  2015        PMID: 26131963      PMCID: PMC4545018          DOI: 10.3791/52885

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  36 in total

1.  Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.

Authors:  Kouichi Hasegawa; Peilin Zhang; Zong Wei; Jordan E Pomeroy; Wange Lu; Martin F Pera
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

Review 2.  Human induced pluripotent stem cells--from mechanisms to clinical applications.

Authors:  Katharina Drews; Justyna Jozefczuk; Alessandro Prigione; James Adjaye
Journal:  J Mol Med (Berl)       Date:  2012-05-30       Impact factor: 4.599

3.  A more efficient method to generate integration-free human iPS cells.

Authors:  Keisuke Okita; Yasuko Matsumura; Yoshiko Sato; Aki Okada; Asuka Morizane; Satoshi Okamoto; Hyenjong Hong; Masato Nakagawa; Koji Tanabe; Ken-ichi Tezuka; Toshiyuki Shibata; Takahiro Kunisada; Masayo Takahashi; Jun Takahashi; Hiroh Saji; Shinya Yamanaka
Journal:  Nat Methods       Date:  2011-04-03       Impact factor: 28.547

4.  Generation of induced pluripotent stem cells with CytoTune, a non-integrating Sendai virus.

Authors:  Pauline T Lieu; Andrew Fontes; Mohan C Vemuri; Chad C Macarthur
Journal:  Methods Mol Biol       Date:  2013

5.  Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector.

Authors:  Andreia Gianotti Sommer; Sarah S Rozelle; Spencer Sullivan; Jason A Mills; Seon-Mi Park; Brenden W Smith; Amulya M Iyer; Deborah L French; Darrell N Kotton; Paul Gadue; George J Murphy; Gustavo Mostoslavsky
Journal:  J Vis Exp       Date:  2012-10-31       Impact factor: 1.355

6.  Trypan blue exclusion test of cell viability.

Authors:  W Strober
Journal:  Curr Protoc Immunol       Date:  2001-05

7.  Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.

Authors:  Bin-Kuan Chou; Prashant Mali; Xiaosong Huang; Zhaohui Ye; Sarah N Dowey; Linda Ms Resar; Chunlin Zou; Y Alex Zhang; Jay Tong; Linzhao Cheng
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

8.  Direct cell reprogramming is a stochastic process amenable to acceleration.

Authors:  Jacob Hanna; Krishanu Saha; Bernardo Pando; Jeroen van Zon; Christopher J Lengner; Menno P Creyghton; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

9.  A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells.

Authors:  Imbisaat Geti; Mark L Ormiston; Foad Rouhani; Mark Toshner; Mehregan Movassagh; Jennifer Nichols; William Mansfield; Mark Southwood; Allan Bradley; Amer Ahmed Rana; Ludovic Vallier; Nicholas W Morrell
Journal:  Stem Cells Transl Med       Date:  2012-11-29       Impact factor: 6.940

10.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.

Authors:  Knut Woltjen; Iacovos P Michael; Paria Mohseni; Ridham Desai; Maria Mileikovsky; Riikka Hämäläinen; Rebecca Cowling; Wei Wang; Pentao Liu; Marina Gertsenstein; Keisuke Kaji; Hoon-Ki Sung; Andras Nagy
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more
  9 in total

1.  Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.

Authors:  Wei Wen; Jian-Ping Zhang; Jing Xu; Ruijun Jeanna Su; Amanda Neises; Guang-Zhen Ji; Weiping Yuan; Tao Cheng; Xiao-Bing Zhang
Journal:  Stem Cell Reports       Date:  2016-05-05       Impact factor: 7.765

Review 2.  Induced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biology.

Authors:  N Rawat; M K Singh
Journal:  Vet World       Date:  2017-06-14

3.  Silencing of CCR4-NOT complex subunits affects heart structure and function.

Authors:  Lisa Elmén; Claudia B Volpato; Anaïs Kervadec; Santiago Pineda; Sreehari Kalvakuri; Nakissa N Alayari; Luisa Foco; Peter P Pramstaller; Karen Ocorr; Alessandra Rossini; Anthony Cammarato; Alexandre R Colas; Andrew A Hicks; Rolf Bodmer
Journal:  Dis Model Mech       Date:  2020-07-20       Impact factor: 5.758

4.  Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.

Authors:  Benedetta Ermon; Claudia B Volpato; Giada Cattelan; Rosamaria Silipigni; Marina Di Segni; Chiara Cantaloni; Michela Casella; Peter P Pramstaller; Giulio Pompilio; Elena Sommariva; Viviana Meraviglia; Alessandra Rossini
Journal:  Stem Cell Res       Date:  2018-09-06       Impact factor: 2.020

Review 5.  Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.

Authors:  Andreas Brodehl; Hans Ebbinghaus; Marcus-André Deutsch; Jan Gummert; Anna Gärtner; Sandra Ratnavadivel; Hendrik Milting
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

6.  A Novel Human Biospecimen Repository for Clinical and Molecular Investigation of Thoracic Aortopathy.

Authors:  Courtney E Vujakovich; Benjamin J Landis
Journal:  Cardiogenetics       Date:  2021-09-18

Review 7.  An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.

Authors:  Siddharth Menon; Siny Shailendra; Andrea Renda; Michael Longaker; Natalina Quarto
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

Review 8.  Adult Neural Stem Cells: Basic Research and Production Strategies for Neurorestorative Therapy.

Authors:  E M Samoilova; V A Kalsin; N M Kushnir; D A Chistyakov; A V Troitskiy; V P Baklaushev
Journal:  Stem Cells Int       Date:  2018-04-01       Impact factor: 5.443

Review 9.  Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform-A Cardiac Perspective.

Authors:  Mohamed M Bekhite; P Christian Schulze
Journal:  Cells       Date:  2021-12-09       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.